The Future of Drug Discovery is Here
AI-powered protein folding and molecular docking in a revolutionary conversational interface. Making world-class drug discovery accessible to everyone.
Join the RevolutionTraditional drug discovery takes 10-15 years and costs an average of $2.6 billion per approved drug. Complex software, expensive infrastructure, and specialized expertise create massive barriers to innovation.
DockQuest democratizes drug discovery with an AI-powered conversational interface that makes protein folding and molecular docking as easy as having a conversation. No specialized training required.
Leveraging state-of-the-art ESM3 models (Meta's breakthrough protein language model) to predict 3D protein structures from sequences in seconds. What once took months in a lab now happens instantly.
Powered by GNINA, a deep learning framework for molecular docking, we predict how potential drugs bind to target proteins with unprecedented accuracy and speed.
Natural language interaction makes complex computational biology accessible to everyone. Just chat with DockQuest - no command lines, no coding, no PhDs required.
Beautiful 3D molecular visualizations update in real-time using 3Dmol.js. See your protein structures and docking results instantly in an interactive web viewer.
Processes that traditionally take days or weeks now complete in minutes. Iterate faster, test more compounds, accelerate discovery.
Built on open-source foundations with flexible deployment options. Run locally for privacy or in the cloud for scale. Your data, your choice.
Our intelligent agent-based pipeline handles the entire drug discovery workflow
Provide a protein sequence in natural language
ESM3 predicts 3D structure in seconds
Prepare drug candidates from SMILES notation
GNINA predicts binding affinity
Interactive 3D visualization and binding scores
DockQuest leverages the latest breakthroughs in AI and computational biology
First conversational drug discovery platform combining ESM3 + GNINA in production
Only platform where a biologist can go from idea to docking results in under 5 minutes without coding
Agent-based pipeline designed for enterprise: extensible, testable, production-ready
Built on modular agent architecture - easily add new AI models, methods, and capabilities
Same algorithms used in top pharma labs, now accessible to everyone
Not just a tool - a platform for the next generation of drug discovery workflows
DockQuest is just the beginning. We're building the conversational AI platform for all of computational biology.
Autonomous agents that collaborate to solve complex biology problems. Let AI handle the pipeline while you focus on science.
Screen millions of compounds against thousands of targets in parallel. Cloud-native architecture for infinite scale.
AI that designs novel drug candidates from scratch, optimized for binding affinity, ADMET properties, and synthesizability.
Built-in analysis of binding energies, RMSD, molecular properties, and more. Turn data into insights automatically.
RESTful API for programmatic access. Integrate with lab information systems, electronic lab notebooks, and existing workflows.
Team collaboration, access controls, audit logs, and compliance features. From startup to Big Pharma.
✨ Web-based GUI for non-technical users
🔐 API platform for developers and enterprises
🌍 Cloud deployment for unlimited scale
🤝 Integration with protein databases (PDB, UniProt, AlphaFold)
📈 ML-powered compound optimization and lead generation
🏆 Marketplace for custom agents and workflows
Watch how DockQuest transforms drug discovery from a months-long process into a simple conversation. Real results, real science, revolutionary simplicity.
Fast iteration, limited resources, need to maximize R&D efficiency
Academic labs needing accessible computational tools without huge budgets
Accelerate early-stage discovery, reduce costs, increase throughput
We're looking for visionary investors who want to revolutionize drug discovery and make life-saving treatments accessible to millions.